Long COVID Brain Fog May Not

Does Long COVID Brain Fog Come From Brain Inflammation?

The study used TSPO PET/MRI, an imaging approach that can detect glial activation, a signal often used in research as a marker of neuroinflammation. Researchers compared people with long COVID symptoms with healthy controls and patients with multiple sclerosis, a neurological disease known to involve inflammatory activity in the central nervous system.

The results suggest that long COVID symptoms such as fatigue, brain fog, anxiety, depression, and post-exertional symptom worsening may not be driven by a simple pattern of global brain inflammation. That matters clinically because it pushes research beyond one-size-fits-all anti-inflammatory explanations and toward more precise biological pathways.

Why Can Long COVID Symptoms Persist If Inflammation Is Not Widespread?

Long COVID is defined by the World Health Organization as symptoms that usually begin or continue three months after SARS-CoV-2 infection and last at least two months with no alternative explanation. Many patients report disabling fatigue, cognitive difficulty, sleep problems, dizziness, palpitations, pain, or mood symptoms, often with symptoms worsening after exertion.

A lack of widespread PET-detectable inflammation does not mean symptoms are imaginary. Other plausible mechanisms include regional brain network dysfunction, immune dysregulation outside the brain, microvascular injury, autonomic nervous system disturbance, mitochondrial stress, persistent sleep disruption, and the effects of severe acute illness in some patients.

What Should Patients With Long COVID Brain Symptoms Do Now?

For patients, the practical message is caution: this study does not identify a cure, and it should not be used to dismiss long COVID. It does suggest that broad anti-inflammatory treatment strategies may not be appropriate for everyone without clearer evidence of inflammation in an individual patient.

Clinical care should focus on documenting symptoms, screening for treatable contributors such as sleep disorders, anemia, thyroid disease, mood disorders, migraine, dysautonomia, medication effects, and cardiopulmonary complications, and using pacing strategies when post-exertional symptom worsening is present. Larger studies are still needed to determine which biological subtypes of long COVID respond to which treatments.